You just read:

Mallinckrodt Announces Positive Top-Line Findings from its Observational Registry Assessing Relapse Recovery in Multiple Sclerosis Relapse Patients Treated with Acthar® Gel (Repository Corticotropin Injection)

News provided by

Mallinckrodt plc

Oct 01, 2019, 06:45 ET